GN ReSound A/S Due Diligence
Run due diligence on GN ReSound A/S: check compliance and get alerts when suppliers or ownership change.
Denmark · owned by GN STORE NORD A/S (Denmark) · gnresound.com · 13 vendors
GN ReSound is a Danish hearing aid manufacturer and one of the world's leading providers of intelligent hearing solutions. The company develops and markets advanced hearing aids and related accessories under the ReSound brand, leveraging wireless connectivity and digital signal processing technologies. It operates as part of the GN Group (GN Store Nord A/S), a global Danish technology company.
Resilience scores
- Digital Sovereignty: 0
- Digital Resilience: 7
- Financial Resilience: 6
Technology vendors
- CSC — Other — United States
- Docker, Inc. — Technology — United States
- ServiceNow, Inc. — Technology — United States
- and 12 more
Insights
Last updated 2026-09-13 · revision 3
13 direct vendors, 200 subvendors
Direct vendors by controlling owner country (sample)
- United States: 11
- Australia: 1
- Canada: 1
Subvendors by controlling owner country (sample)
- Poland: 1
- India: 1
- Denmark: 2
Financials
Three-year financials
- 2023: revenue DKK 6.9B, EBIT DKK 950M
- 2022: revenue DKK 6.56B, EBIT DKK 900M
- 2021: revenue DKK 6.6B, EBIT DKK 1.4B
Financial Resilience Score: 6/10
GN ReSound A/S sits inside the listed GN Store Nord group, which provides access to bank facilities and capital markets, and benefits from a strong global brand portfolio (ReSound, Beltone, Interton, Jabra Enhance, ReSound Nexia) along with technology leadership in Bluetooth Low Energy Audio/Auracast. The business has diversified channels including independent audiologists, retail chains, government tenders (U.S. VA, UK NHS), and direct-to-consumer, supported by structural demand from ageing demographics. However, GN Hearing's EBITA margin contracted sharply in 2022 (from ~21% to ~14%) and has only partially recovered, trailing competitor Sonova. The parent group took on significant debt around the SteelSeries acquisition, leading to a ~DKK 7 billion rights issue in 2023 to deleverage, with refinancing risk remaining a watch item. Competitive intensity from Sonova, Demant, WS Audiology and Starkey, plus the U.S. OTC hearing aid rule (2022), adds pricing pressure. FX exposure (USD/EUR vs DKK) and product launch execution risk (illustrated by the OMNIA delay in 2022) further weigh on resilience.
Key strengths: Backed by listed, well-capitalised parent GN Store Nord with capital markets access, Strong global brand portfolio (ReSound, Beltone, Interton, Jabra Enhance, Nexia), Technology leadership in Bluetooth LE Audio / Auracast, Diversified channel mix including professional, government tenders, and DTC, Recurring demand from ageing demographics in core markets
Risk factors: Margin pressure: EBITA margin contracted from ~21% (2021) to ~14% (2022-2023), High leverage at group level following SteelSeries acquisition; required DKK 7B rights issue in 2023, Intense competition from Sonova, Demant, WS Audiology, Starkey, U.S. OTC hearing aid rule (2022) creating new pricing pressure, FX exposure to USD and EUR vs DKK reporting, Product launch execution risk (e.g., OMNIA delay in 2022)
Revenue by geography
- North America: 53%
- Europe: 30%
- Rest of World (APAC, Latin America, MEA): 17%
Revenue by product/service
- Hearing aids (ReSound, Beltone, Interton professional channel): 87%
- Direct-to-consumer (Jabra Enhance / Lively): 8%
- Audiological diagnostic equipment and accessories: 5%
Workforce by country
- Denmark: 1000
Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.